Aeris Capital AG

Aeris Capital AG was a Zurich, Switzerland-based private equity fund and financial advisor that rebranded to Calibrium AG in February 2017.

Venture Capital Active Zurich, Switzerland Est. 2006
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
total disclosed, rounds participated
Stages

About

Aeris Capital AG was a private equity fund and financial advisor based in Zurich, Switzerland. It acted as a financial advisor to the investment interests associated with a European family. The firm specialized in identifying and investing in early-stage and growth-stage technology companies across Europe. In February 2017, Aeris Capital AG rebranded to Calibrium AG.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

Portfolio by sector

Agriculture & Food Technologies1

Q&A

What is Aeris Capital AG's primary sector focus for investments?
Aeris Capital AG has shown a focus on the Agriculture & Food Technologies sector, with one investment round and one portfolio company in this area.
Can you name a notable portfolio company of Aeris Capital AG?
Atlantium Technologies, a company focused on UV Disinfection Systems for Water Treatment, is a notable portfolio company of Aeris Capital AG.
What stage of funding does Aeris Capital AG typically participate in?
Aeris Capital AG has participated in C Round funding stages, as seen with their investment in Atlantium Technologies.
When did Aeris Capital AG make its most recent recorded investment?
Aeris Capital AG's most recent recorded investment occurred in February 2013.
What is the typical investment range for Aeris Capital AG?
Aeris Capital AG's investment range is stated as $9M - $9M.
Has Aeris Capital AG had any exits from its portfolio companies?
According to startupim data, Aeris Capital AG has not recorded any exits from its portfolio companies.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2006

Radar intelligence

Patents

EPO10